» Articles » PMID: 27433170

Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014

Overview
Specialty Pulmonary Medicine
Date 2016 Jul 20
PMID 27433170
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is a prevalent and serious health problem in Korea. Recently, the Korean Asthma Guideline has been updated by The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD) in an effort to improve the clinical management of asthma. This guideline focuses on adult patients with asthma and aims to deliver up to date scientific evidence and recommendations to general physicians for the management of asthma. For this purpose, this guideline was updated following systematic review and meta-analysis of recent studies and adapting some points of international guidelines (Global Initiative for Asthma [GINA] report 2014, National Asthma Education and Prevention Program [NAEPP] 2007, British Thoracic Society [BTS/SIGN] asthma guideline 2012, and Canadian asthma guideline 2012). Updated issues include recommendations derived using the population, intervention, comparison, and outcomes (PICO) model, which produced 20 clinical questions on the management of asthma. It also covers a new definition of asthma, the importance of confirming various airflow limitations with spirometry, the epidemiology and the diagnostic flow of asthma in Korea, the importance and evidence for inhaled corticosteroids (ICS) and ICS/formoterol as a single maintenance and acute therapy in the stepwise management of asthma, assessment of severity of asthma and management of exacerbation, and an action plan to cope with exacerbation. This guideline includes clinical assessments, and treatment of asthma-chronic obstructive pulmonary disease overlap syndrome, management of asthma in specific conditions including severe asthma, elderly asthma, cough variant asthma, exercise-induced bronchial contraction, etc. The revised Korean Asthma Guideline is expected to be a useful resource in the management of asthma.

Citing Articles

Expert opinion on gray areas in asthma management: A lesson from the innovative project "revolution in asthma" of the Italian thoracic society (AIPO-ITS).

Vaghi A, Antonelli Incalzi R, Barbaglia S, Bilo M, Bini F, Carone M Clin Transl Allergy. 2025; 15(2):e70037.

PMID: 39924642 PMC: 11807766. DOI: 10.1002/clt2.70037.


Efficacy and Safety of Montelukast+Levocetirizine Combination Therapy Compared to Montelukast Monotherapy for Allergic Rhinitis in Children.

Kim C, Hwang Y, Song D, Yu J, Sohn M, Park Y Allergy Asthma Immunol Res. 2024; 16(6):652-667.

PMID: 39622689 PMC: 11621474. DOI: 10.4168/aair.2024.16.6.652.


SABAs as Reliever Medications in Asthma Management: Evidence-Based Science.

Amirav I, Garcia G, Le B, Barria P, Levy G, Aggarwal B Adv Ther. 2023; 40(7):2927-2943.

PMID: 37280414 PMC: 10244083. DOI: 10.1007/s12325-023-02543-9.


Summary of Korean Asthma Guideline.

Rhee C, Moon J, Joo H, Jung J, Lee J, Min K Tuberc Respir Dis (Seoul). 2023; 86(3):158-165.

PMID: 37254491 PMC: 10323208. DOI: 10.4046/trd.2023.0052.


Relationships Between High-Resolution Computed Tomographic Features and Lung Function Trajectory in Patients With Asthma.

Kim J, Shin K, Chang H, Lee J, Park S, Soung Park J Allergy Asthma Immunol Res. 2023; 15(2):174-185.

PMID: 37021504 PMC: 10079522. DOI: 10.4168/aair.2023.15.2.174.


References
1.
Castro M, Rubin A, Laviolette M, Fiterman J, De Andrade Lima M, Shah P . Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. 2009; 181(2):116-24. PMC: 3269231. DOI: 10.1164/rccm.200903-0354OC. View

2.
Brouwers M, Kho M, Browman G, Burgers J, Cluzeau F, Feder G . AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010; 182(18):E839-42. PMC: 3001530. DOI: 10.1503/cmaj.090449. View

3.
Juniper E, KLINE P, Vanzieleghem M, Ramsdale E, OByrne P, Hargreave F . Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990; 142(4):832-6. DOI: 10.1164/ajrccm/142.4.832. View

4.
Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B . Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000; 343(5):332-6. DOI: 10.1056/NEJM200008033430504. View

5.
Manser R, Reid D, Abramson M . Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev. 2001; (1):CD001740. DOI: 10.1002/14651858.CD001740. View